当前位置:首页 - 行情中心 - 丸美生物(603983) - 财务分析

丸美生物

(603983)

  

流通市值:168.82亿  总市值:168.82亿
流通股本:4.01亿   总股本:4.01亿

丸美生物(603983)财务分析

净利润 + 每股收益
Created with Highcharts 9.1.003-3112-3109-3006-3001.22.43.600.40.81.2
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润1.35亿元,每股收益0.34元。

股东权益 + 未分配利润
Created with Highcharts 9.1.003-3112-3109-3006-30015304517.619.220.822.4
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益358078.52万元,未分配利润215425.33万元。

总资产 + 负债
Created with Highcharts 9.1.003-3112-3109-3006-3002040606121824
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产477978.92万元,负债119900.40万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入846,648,701.632,969,770,566.541,952,334,354.861,352,290,860.56
营业总成本684,279,945.762,610,212,848.291,695,030,314.161,145,366,644.61
营业利润165,983,550.75380,936,810.22282,138,847.2224,648,234.48
利润总额166,151,487.8380,656,508.96282,160,226.33224,659,830.54
净利润135,197,697.18342,363,890.32239,788,683.89177,028,019.56
其他综合收益-59,597.35-124,364.71-53,319.78-12,121.29
综合收益总额135,138,099.83342,239,525.61239,735,364.11177,015,898.27
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计2,641,018,361.332,954,402,626.082,596,435,890.882,321,516,986.33
非流动资产合计2,138,770,852.452,108,161,468.731,838,572,800.761,991,625,417.17
资产总计4,779,789,213.785,062,564,094.814,435,008,691.644,313,142,403.5
流动负债合计1,180,868,219.111,596,540,138.86969,555,755.82906,062,269.12
非流动负债合计18,135,803.8319,520,458.1921,746,310.8125,134,762.74
负债合计1,199,004,022.941,616,060,597.05991,302,066.63931,197,031.86
归属于母公司股东权益合计3,515,392,384.833,380,406,892.853,377,359,780.473,315,134,804.07
股东权益合计3,580,785,190.843,446,503,497.763,443,706,625.013,381,945,371.64
负债和股东权益合计4,779,789,213.785,062,564,094.814,435,008,691.644,313,142,403.5
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计954,056,827.42,777,639,441.461,920,298,243.911,259,531,556.22
经营活动现金流出小计981,644,388.672,477,112,583.111,851,874,733.421,200,948,559.72
经营活动产生的现金流量净额-27,587,561.27300,526,858.3568,423,510.4958,582,996.5
投资活动现金流入小计96,330,024.031,400,120,250.131,052,260,842.69677,330,340.46
投资活动现金流出小计124,236,457.12967,928,649.87757,875,811.57483,688,388.4
投资活动产生的现金流量净额-27,906,433.09432,191,600.27294,385,031.12193,641,952.06
筹资活动现金流入小计-786,676,783.33379,518,827.78248,180,000
筹资活动现金流出小计151,633,336.23979,825,800.28467,388,143.43462,616,049.44
筹资活动产生的现金流量净额-151,633,336.23-193,149,016.95-87,869,315.65-214,436,049.44
汇率变动对现金及现金等价物的影响20,332.55-48,386.26-35,217.93-238,288.08
现金及现金等价物净增加额-207,106,998.04539,521,055.4274,904,008.0337,550,611.04
期末现金及现金等价物余额1,371,953,011.91,579,060,009.941,314,442,962.571,077,089,565.58
最新报告期:2025-05-26
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
长江证券李锦,罗祎1.111.441.872025-05-26
中泰证券张前,郑澄怀1.121.431.812025-05-21
中信建投于佳琪,刘乐文1.161.511.902025-05-08
东北证券李森蔓1.131.441.812025-05-02
西部证券吴岑1.141.451.782025-05-01
TOP↑